Reminder: Login to access new features and members-only content!

Register to be a member of our community. Its easy!

Register a new account

Already a member?

Log In here!

Donate

Did you find our content interesting or helpful? Help support the IPFD enhance health, well-being and welfare for dogs everywhere.

Jump to content
  •   Language
  • Sign Up

International Partnership for Dogs - Enhancing Dog Health, Well-Being, and Welfare - Join Us.

Fanconi Syndrome

Breed: Hokkaido

Breeds

Relevance Rating: The test is unknown, there is no evidence (i.e. research) available, or it has not been evaluated yet. These tests may or may not be meaningful in this breed

General

Disease Name
Fanconi Syndrome
Mutation
321bp deletion
Test Type
Genetic Disease/Disorder
Details
Fanconi syndrome causes the proximal renal tubules of the kidney to not properly reabsorb electrolytes and nutrients back into the body, but instead "spill" them in the urine. Symptoms include excessive drinking, excessive urination, and glucose in the urine. If Fanconi is left untreated, muscle wasting, acidosis, and poor condition will also occur. Age of onset on average between 4 and 8 years of age. Since the disease is typically not discovered until the dog is older, the condition is often passed on to offspring as it was not known that the parent was affected. Fanconi syndrome is progressive, and left untreated can be fatal.
Details 2
Fanconi syndrome causes the proximal renal tubules of the kidney to not properly reabsorb electrolytes and nutrients back into the body, but instead "spill" them in the urine. Symptoms include excessive drinking (polydipsia), excessive urination (polyuria), and glucose in the urine (glucosuria.) If Fanconi is left untreated, muscle wasting, acidosis, and poor condition will also occur.
Published
Farias, F.H.G. : Molecular genetic studies of canine inherited diseases. PhD thesis, University of Missouri http://hdl.handle.net/10355/14514 :, 2011.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.